Summary

The Vitamin K2 market is projected to reach USD 339.9 million by 2031 from USD 179.0 million in 2026, at a CAGR of 13.7% from 2026 to 2031. This growth is propelled by increasing awareness of consumers regarding bone and cardiovascular health, increasing demand for preventive healthcare, and rising adoption of dietary supplements and functional nutrition products. Consumers are increasingly prioritizing long-term health and wellness, resulting in higher demand for Vitamin K2 ingredients that support calcium metabolism, bone mineralization, and cardiovascular health. In addition, the growing preference for scientifically validated, clean-label, and naturally derived ingredients is encouraging the adoption of fermentation-based Vitamin K2 across dietary supplements, functional foods and beverages, and pharmaceutical applications. The expanding aging population, increasing incidence of osteoporosis and cardiovascular disorders, and rising healthcare expenditure are further supporting market expansion across developed and emerging economies.

Manufacturers are continuously investing in product innovation and advanced production technologies to improve the purity, stability, and bioavailability of Vitamin K2 ingredients. There is a growing focus on developing high-quality MK7 and MK4 formulations through natural fermentation, chemical synthesis, and biotechnological fermentation technologies to meet evolving customer and regulatory requirements. Advancements in purifying processes, microencapsulation technologies, and formulation solutions are enabling manufacturers to enhance ingredient stability and application diversity across multiple product formats. Additionally, increasing scientific research, expanding regulatory approvals, and growing incorporation of Vitamin K2 into personalized nutrition solutions and functional health products are creating new growth opportunities for market participants. However, challenges such as stringent regulatory requirements, limited consumer awareness in developing regions, raw material and production costs, and increasing competition among manufacturers may restrain market growth.

By product type, the MK-7 segment is expected to be the dominant segment in the market.
By product type, the MK-7 segment is projected to be the dominant segment in the market. Vitamin K2 MK7, specifically MenaQ7 and vitaMK7, represents a pivotal advancement in nutritional science, renowned for its dual benefits in bone and cardiovascular health. Distinct from its K1 counterpart, K2 MK-7's superior bioavailability and extended half-life in the body make it optimal for promoting calcium utilization towards bone strength while preventing arterial calcification. Its role in activating key proteins like osteocalcin and Matrix Gla Protein (MGP) underscores its efficacy in supporting skeletal integrity and cardiovascular flexibility. As consumer awareness grows and dietary deficiencies persist, the market potential for K2 MK-7 continues to expand, driven by increasing demand for scientifically validated supplements that address fundamental health challenges across diverse demographic segments.

The pharmaceuticals segment in the Vitamin K2 market is projected to have significant growth during the forecast period.
Vitamin K2 has shown various potential benefits in pharmaceutical applications, which are expected to drive demand for this ingredient in the industry. However, there is a stringent regulatory structure for the usage of Vitamin K2 in pharmaceutical applications across regions. Multiple primary industry experts from various Vitamin K2 manufacturers agreed that the usage of Vitamin K2 in pharmaceutical applications is limited to Asia Pacific; within this region, although some countries manufacture Vitamin K2 for pharmaceutical applications, the consumption is mainly observed in China and Japan. Thus, recent government insights, along with ongoing research and clinical trials, support the potential benefits of Vitamin K2 in pharmaceutical applications.

Asia Pacific is projected to be the fastest-growing region in the global Vitamin K2 market during the forecast period.
The Asia Pacific region is emerging as the fastest-growing market for Vitamin K2, driven by a combination of demographic, economic, and lifestyle factors. One of the primary drivers of this growth is the region's rapidly aging population. Countries such as Japan, China, and South Korea are experiencing significant increases in their elderly populations, who are more prone to bone-related ailments like osteoporosis and cardiovascular issues. This demographic shift is creating a substantial demand for nutritional supplements that support bone health and prevent arterial calcification, making Vitamin K2 a sought-after nutrient.

Additionally, the robust growth of the e-commerce sector in the Asia Pacific (APAC) region has significantly facilitated easy access to a wide range of Vitamin K2 products, contributing to the market's expansion. One of the main advantages is the proliferation of online retail platforms, such as Amazon, Alibaba, and other regional e-commerce giants. These platforms have not only increased the visibility of Vitamin K2 supplements but have also allowed for a broader distribution network, reaching consumers in even the most remote areas.

In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the Vitamin K2 market.

- By Company Type: Tier 1 – 30%, Tier 2 – 25%, and Tier 3 – 45%
- By Designation: CXOs – 25%, Managers – 35%, Others – 40%

Prominent companies in the market include Gnosis by Lesaffre (France), Balchem Corporation (US), J-OIL MILLS, INC. (Japan), Novonesis A/S (Denmark), Guangdong Sungen Bioscience Co., Ltd. (China), Vesta Nutra (US), and others.

Research Coverage
This research report categorizes the Vitamin K2 market by product type (MK4 and MK7), application form (capsules and tablets, powder and crystalline, and liquids), source (natural and synthetic), application (pharmaceuticals, functional foods and beverages, and health supplements), function (bone and cardiovascular health, blood health and clotting, anti-inflammatory and immunity, and other functions), processing technology (natural fermentation, chemical synthesis, biotechnological fermentation, and other production technologies) and region (North America, Europe, Asia Pacific, and Rest of the World).

The report’s scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the Vitamin K2 industry. A thorough analysis of the key industry players has been carried out to provide insights into their business, services, key strategies, contracts, partnerships, agreements, service launches, mergers & acquisitions, and recent developments associated with the Vitamin K2 market. This report provides a competitive analysis of emerging startups in the Vitamin K2 market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others.

Reasons to Buy This Report
The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall Vitamin K2 and its subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:
- Analysis of key drivers (rising health consciousness among consumers), restraints (inconsistency in regulatory norms), opportunities (growing demand for natural and plant-based ingredients), and challenges (lack of consumer awareness regarding specific health benefits of Vitamin k2) influencing the growth of the Vitamin K2 market
- Product Development/Innovation: Detailed insights into research & development activities and product launches in the Vitamin K2 market
- Market Development: Comprehensive information about lucrative market analysis of Vitamin K2 across varied regions
- Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the Vitamin K2 market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as Gnosis by Lesaffre (France), Balchem Corporation (US), J-OIL MILLS, INC. (Japan), Novonesis A/S (Denmark), Guangdong Sungen Bioscience Co., Ltd. (China), Vesta Nutra (US), Shandong Richen Nutritional Technology Co., Ltd. (China), Menadiona S.L. (Spain), GF Fermentech Co., Ltd. (South Korea), Angel Yeast Co., Ltd. (China), GeneFerm Biotechnology Co., Ltd. (Taiwan), Nakoda Chemicals Ltd. (India), Haihang Industry Co., Ltd. (China), Chemicea Limited (India), and Kyowa Hakko U.S.A., Inc. (US) in the Vitamin K2 market

ページTOPに戻る

Table of Contents

1 INTRODUCTION 27
1.1 STUDY OBJECTIVES 27
1.2 MARKET DEFINITION 27
1.3 STUDY SCOPE AND SEGMENTATION 27
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 28
1.3.2 INCLUSIONS AND EXCLUSIONS 28
1.3.3 YEARS CONSIDERED 29
1.3.4 CURRENCY CONSIDERED 30
1.3.5 UNIT CONSIDERED 30
1.4 STAKEHOLDERS 31
1.5 SUMMARY OF CHANGES 31

2 EXECUTIVE SUMMARY 32
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 32
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 34
2.3 DISRUPTIVE TRENDS IN VITAMIN K2 MARKET 35
2.4 HIGH-GROWTH SEGMENTS 36
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 37

3 PREMIUM INSIGHTS 38
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN VITAMIN K2 MARKET 38
3.2 VITAMIN K2 MARKET, BY APPLICATION FORM AND REGION 39
3.3 VITAMIN K2 MARKET, BY SOURCE 39
3.4 VITAMIN K2 MARKET, BY APPLICATION 40
3.5 VITAMIN K2 MARKET, BY PRODUCT TYPE 40
3.6 VITAMIN K2 MARKET, BY APPLICATION FORM 41
3.7 VITAMIN K2 MARKET, BY COUNTRY 41

4 MARKET OVERVIEW 42
4.1 INTRODUCTION 42
4.2 MARKET DYNAMICS 43
4.2.1 DRIVERS 43
4.2.1.1 Rising health consciousness among consumers 43
4.2.1.2 Increasing research and development activities 44
4.2.1.3 Growing aging population and rising prevalence of
bone & cardiovascular disorders 45
4.2.2 RESTRAINTS 45
4.2.2.1 Inconsistency in regulatory norms 45
4.2.2.2 Price volatility of raw materials 46
4.2.3 OPPORTUNITIES 46
4.2.3.1 Growing demand for natural and plant-based ingredients 46
4.2.3.2 Rising need for personalized nutrition and customized products 47
4.2.3.3 Untapped applications 47
4.2.4 CHALLENGES 48
4.2.4.1 Lack of consumer awareness regarding specific health benefits 48
4.2.4.2 High research and development costs 48
4.3 UNMET NEEDS AND WHITE SPACES 49
4.3.1 UNMET NEEDS IN VITAMIN K2 MARKET 49
4.3.2 WHITE SPACE OPPORTUNITIES 50
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 51
4.4.1 INTERCONNECTED MARKETS 51
4.4.2 CROSS-SECTOR OPPORTUNITIES 52
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 53
4.5.1 KEY MOVES AND STRATEGIC FOCUS 53

5 INDUSTRY TRENDS 55
5.1 PORTER’S FIVE FORCES ANALYSIS 55
5.1.1 INTENSITY OF COMPETITIVE RIVALRY 56
5.1.2 BARGAINING POWER OF SUPPLIERS 56
5.1.3 BARGAINING POWER OF BUYERS 56
5.1.4 THREAT OF SUBSTITUTES 56
5.1.5 THREAT OF NEW ENTRANTS 57
5.2 MACROECONOMICS OUTLOOK 57
5.2.1 INTRODUCTION 57
5.2.1.1 Macroeconomic indicators 57
5.2.1.1.1 Rising world GDP and population 57
5.2.1.1.2 Rise in health concerns and disease incidences 59
5.3 VALUE CHAIN ANALYSIS 60
5.3.1 RESEARCH AND DEVELOPMENT 60
5.3.2 RAW MATERIAL SOURCING 61
5.3.3 PRODUCTION AND PROCESSING 61
5.3.4 QUALITY ASSURANCE 61
5.3.5 MARKETING, DISTRIBUTION, & SALES 61
5.3.6 END USERS 62
5.4 ECOSYSTEM ANALYSIS 62
5.4.1 DEMAND SIDE 62
5.4.2 SUPPLY SIDE 62
5.5 PRICING ANALYSIS 64
5.5.1 INTRODUCTION 64
5.5.2 AVERAGE SELLING PRICE (ASP) TREND, BY PRODUCT TYPE,
2022–2025 (USD/TONS) 64
5.5.3 AVERAGE SELLING PRICE (ASP) TREND, BY REGION,
2022–2025 (USD/TONS) 64
5.6 TRADE ANALYSIS 65
5.6.1 IMPORT ANALYSIS: VITAMINS AND THEIR DERIVATIVES 66
5.6.2 EXPORT ANALYSIS: VITAMINS AND THEIR DERIVATIVES 67
5.7 KEY CONFERENCES AND EVENTS, 2026–2027 68
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 68
5.9 INVESTMENT AND FUNDING SCENARIO 69
5.10 CASE STUDY ANALYSIS 70
5.10.1 GNOSIS BY LESAFFRE – LAUNCH OF MENAQ7 OLIVE OIL 70
5.10.2 BALCHEM CORP.– ACQUISITION OF KAPPA BIOSCIENCE 70
5.11 IMPACT OF 2025 US TARIFF – VITAMIN K2 MARKET 71
5.11.1 INTRODUCTION 71
5.11.2 PRICE IMPACT ANALYSIS 72
5.11.3 IMPACT ON COUNTRIES/REGIONS 72
5.11.3.1 US 72
5.11.3.2 Europe 72
5.11.3.3 Asia Pacific 72
5.11.4 IMPACT ON END-USE INDUSTRIES 73

6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS,
INNOVATIONS, AND FUTURE APPLICATIONS 74
6.1 TECHNOLOGY ANALYSIS 74
6.1.1 KEY TECHNOLOGIES 74
6.1.1.1 Fermentation technology 74
6.1.1.2 Bioreactor process control technology 74
6.1.2 COMPLEMENTARY ANALYSIS 75
6.1.2.1 Encapsulation technology 75
6.1.2.2 Spray drying technology 75
6.1.3 ADJACENT TECHNOLOGIES 75
6.1.3.1 Synthetic biology 75
6.1.3.2 Continuous manufacturing technology 75
6.1.4 TECHNOLOGY/PRODUCT ROADMAP 75
6.1.4.1 Short-term | Process optimization & high-purity ingredient expansion 76
6.1.4.2 Mid-term | Personalized nutrition & sustainable bioprocessing 76
6.1.4.3 Long-term | Synthetic biology & next-generation precision health 76
6.2 PATENT ANALYSIS 77
6.3 FUTURE APPLICATIONS 78
6.3.1 AI-DRIVEN PRECISION FERMENTATION: OPTIMIZING VITAMIN K2 PRODUCTION 79
6.3.2 SYNTHETIC BIOLOGY: ENGINEERING HIGH-PERFORMANCE
MICROBIAL STRAINS 79
6.3.3 PRECISION NUTRITION & PERSONALIZED SUPPLEMENTATION:
ADVANCING PREVENTIVE HEALTHCARE 80
6.3.4 ADVANCED DELIVERY SYSTEMS & SMART FORMULATIONS:
IMPROVING BIOAVAILABILITY 80
6.3.5 DIGITAL MANUFACTURING & SMART QUALITY CONTROL:
ENHANCING PRODUCTION EFFICIENCY 81
6.4 IMPACT OF GENERATIVE AI ON VITAMIN K2 MARKET 81
6.4.1 INTRODUCTION 81
6.4.2 CASE STUDIES OF AI IMPLEMENTATION IN VITAMIN K2 MARKET 82
6.4.3 INTERCONNECTED ADJACENT ECOSYSTEM AND
IMPACT ON MARKET PLAYERS 82
6.4.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN VITAMIN K2 MARKET 83
6.5 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 83

7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 84
7.1 REGIONAL REGULATIONS AND COMPLIANCE 84
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
7.1.2 INDUSTRY STANDARDS 86
7.1.3 LABELING REQUIREMENTS AND CLAIMS 87
7.1.4 ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS 88
7.1.4.1 Enhanced ingredient traceability and supply chain transparency 88
7.1.4.2 Greater harmonization of global regulatory standards 88
7.1.4.3 Stricter sustainability and responsible manufacturing requirements 89
7.1.4.4 Digital compliance, smart manufacturing, and quality management 89
7.1.4.5 Expanded regulation of novel production technologies and
health claims 89
7.1.4.6 Strengthened labeling and consumer transparency requirements 89
7.2 SUSTAINABILITY INITIATIVES 89
7.2.1 SUSTAINABLE SOURCING 89
7.2.2 CARBON FOOTPRINT REDUCTION INITIATIVES 90
7.2.3 CIRCULAR ECONOMY APPROACHES 91
7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 91
7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS 92

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 94
8.1 DECISION-MAKING PROCESS 94
8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 95
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 95
8.2.2 BUYING CRITERIA 97
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 98
8.4 UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN 99
8.5 MARKET PROFITABILITY 101
8.6 REVENUE POTENTIAL 101
8.6.1 COST DYNAMICS 101
8.6.2 MARGIN OPPORTUNITIES, BY PRODUCT TYPE 103

9 VITAMIN K2 MARKET, BY FUNCTION 104
9.1 INTRODUCTION 104
9.2 BONE AND CARDIOVASCULAR HEALTH 105
9.2.1 RISING PREVALENCE OF OSTEOPOROSIS AND CARDIOVASCULAR DISORDERS TO DRIVE VITAMIN K2 ADOPTION IN BONE AND CARDIOVASCULAR HEALTH FORMULATIONS 105
9.3 BLOOD HEALTH AND CLOTTING 105
9.3.1 EFFICACY IN MANAGING CLOTTING DISORDERS TO BOOST MARKET GROWTH 105
9.4 ANTI-INFLAMMATORY AND IMMUNITY 106
9.4.1 THERAPEUTIC POTENTIAL AND IMMUNITY-SUPPORTING PROPERTIES TO SUPPORT MARKET GROWTH 106
9.5 OTHER FUNCTIONS 107

10 VITAMIN K2 MARKET, BY PRODUCTION TECHNOLOGY 108
10.1 INTRODUCTION 108
10.2 NATURAL FERMENTATION 109
10.2.1 PREFERRED PRODUCTION TECHNOLOGY FOR PREMIUM VITAMIN K2 (MK-7) DUE TO SUPERIOR BIOAVAILABILITY, NATURAL ORIGIN, AND STRONG CONSUMER ACCEPTANCE 109
10.3 CHEMICAL SYNTHESIS 109
10.3.1 COST-EFFECTIVE PRODUCTION AND HIGH MANUFACTURING SCALABILITY, PARTICULARLY FOR VITAMIN K2 (MK-4) 109
10.4 BIOTECHNOLOGICAL FERMENTATION 110
10.4.1 ENHANCES PRODUCTION EFFICIENCY THROUGH ADVANCED MICROBIAL ENGINEERING AND PRECISION BIOPROCESS TECHNOLOGIES 110
10.5 OTHER PRODUCTION TECHNOLOGIES 110

11 VITAMIN K2 MARKET, BY PRODUCT TYPE 111
11.1 INTRODUCTION 112
11.2 MK7 114
11.2.1 HIGH BIOAVAILABILITY TO PROPEL MARKET GROWTH 114
11.3 MK4 116
11.3.1 POTENTIAL BENEFITS IN BONE AND CARDIOVASCULAR HEALTH TO
DRIVE MARKET 116

12 VITAMIN K2 MARKET, BY SOURCE 119
12.1 INTRODUCTION 120
12.2 NATURAL 121
12.2.1 INCREASING CONSUMER PREFERENCE FOR NON-GMO SUPPLEMENTS TO BOOST MARKET GROWTH 121
12.3 SYNTHETIC 122
12.3.1 LOW PRODUCTION COST TO DRIVE MARKET 122

13 VITAMIN K2 MARKET, BY APPLICATION 124
13.1 INTRODUCTION 125
13.2 HEALTH SUPPLEMENTS 126
13.2.1 GROWING ADOPTION OF PREVENTIVE NUTRITION AND CLINICALLY SUPPORTED DIETARY SUPPLEMENTS TO DRIVE SEGMENT 126
13.3 FUNCTIONAL FOOD & BEVERAGES 129
13.3.1 GROWING DEMAND FOR FORTIFIED FUNCTIONAL FOODS TO
PROPEL MARKET GROWTH 129
13.4 PHARMACEUTICALS 131
13.4.1 RISING INVESTMENTS FOR DEVELOPING NEW FORMULATIONS TO
DRIVE MARKET 131

14 VITAMIN K2 MARKET, BY APPLICATION FORM 134
14.1 INTRODUCTION 135
14.2 CAPSULES & TABLETS 136
14.2.1 ABILITY TO CATER TO DIVERSE CONSUMER NEEDS AND
PREFERENCES TO DRIVE MARKET 136
14.3 POWDER & CRYSTALLINE 137
14.3.1 SURGING DEMAND FOR CUSTOMIZABLE DOSAGES AND HIGH PURITY TO PROPEL MARKET GROWTH 137
14.4 LIQUIDS 138
14.4.1 GROWING NEED FOR SUPPLEMENTS WITH ENHANCED BIOAVAILABILITY TO BOOST SEGMENT GROWTH 138

15 VITAMIN K2 MARKET, BY REGION 139
15.1 INTRODUCTION 140
15.2 NORTH AMERICA 142
15.2.1 US 147
15.2.1.1 Growing awareness about preventive health measures to drive market 147
15.2.2 CANADA 147
15.2.2.1 Increasing focus on preventive healthcare and natural products to propel market 147
15.2.3 MEXICO 148
15.2.3.1 High prevalence of chronic lifestyle diseases to drive market 148
15.3 EUROPE 149
15.3.1 GERMANY 154
15.3.1.1 Rising focus on proactive healthcare to drive market 154
15.3.2 FRANCE 155
15.3.2.1 Investments in R&D and product innovation to boost market growth 155
15.3.3 UK 155
15.3.3.1 Rapidly aging population to propel market growth 155
15.3.4 ITALY 156
15.3.4.1 Aging population and preventive healthcare trends to support vitamin K2 adoption 156
15.3.5 SPAIN 157
15.3.5.1 Growing consumer interest in health supplements to drive demand 157
15.3.6 REST OF EUROPE 158
15.4 ASIA PACIFIC 159
15.4.1 CHINA 164
15.4.1.1 Surging use of digital media to disseminate healthcare information to propel market 164
15.4.2 JAPAN 165
15.4.2.1 Consumer preferences for natural healthcare solutions to boost market growth 165
15.4.3 INDIA 166
15.4.3.1 Strategic market penetration initiatives by various companies to drive market 166
15.4.4 AUSTRALIA AND NEW ZEALAND 167
15.4.4.1 Changing consumer preferences and increasing health consciousness to drive demand 167
15.4.5 REST OF ASIA PACIFIC 168
15.5 REST OF THE WORLD 169
15.5.1 SOUTH AMERICA 173
15.5.1.1 Rising preventive healthcare awareness and expanding nutraceutical industry to support market growth 173
15.5.2 MIDDLE EAST & AFRICA 174
15.5.2.1 Rising healthcare investments and growing preventive nutrition awareness to support market growth 174

16 COMPETITIVE LANDSCAPE 176
16.1 OVERVIEW 176
16.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN 2021–2026 176
16.3 REVENUE ANALYSIS, 2023–2025 177
16.4 MARKET SHARE ANALYSIS, 2025 179
16.4.1 BRAND COMPARISON 182
16.4.2 NOVONESIS GROUP (MENAQUINGOLD) 182
16.4.3 GNOSIS BY LESAFFRE (MENAQ7) 183
16.4.4 BALCHEM CORP. (K2VITAL) 183
16.4.5 GUANGDONG SUNGEN BIOSCIENCE CO., LTD. (ESSEK2) 183
16.4.6 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.) (MENNATO) 183
16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 184
16.5.1 STARS 184
16.5.2 EMERGING LEADERS 184
16.5.3 PERVASIVE PLAYERS 184
16.5.4 PARTICIPANTS 185
16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 186
16.5.5.1 Company footprint 186
16.5.5.2 Region footprint 187
16.5.5.3 Application footprint 188
16.5.5.4 Product type footprint 189
16.6 COMPANY EVALUATION MATRIX: DISTRIBUTORS/SUPPLIERS 189
16.6.1 PROGRESSIVE COMPANIES 189
16.6.2 RESPONSIVE COMPANIES 189
16.6.3 DYNAMIC COMPANIES 190
16.6.4 STARTING BLOCKS 190
16.6.5 COMPETITIVE BENCHMARKING: DISTRIBUTORS/SUPPLIERS, 2025 191
16.6.5.1 Detailed list of key distributors/suppliers 191
16.6.5.2 Competitive benchmarking of key distributors/suppliers 191
16.7 COMPANY VALUATION AND FINANCIAL METRICS 192
16.7.1 COMPANY VALUATION 192
16.7.2 EV/EBITDA 192
16.8 COMPETITIVE SCENARIO 192
16.8.1 PRODUCT LAUNCHES/DEVELOPMENTS 193
16.8.2 DEALS 195
16.8.3 EXPANSIONS 197
16.8.4 OTHER DEVELOPMENTS 198

17 COMPANY PROFILES 199
17.1 KEY PLAYERS (MANUFACTURERS) 199
17.1.1 GNOSIS BY LESAFFRE 199
17.1.1.1 Business overview 199
17.1.1.2 Products/Solutions/Services offered 200
17.1.1.3 Recent developments 201
17.1.1.3.1 Product launches/developments 201
17.1.1.3.2 Deals 201
17.1.1.4 MnM view 202
17.1.1.4.1 Right to win 202
17.1.1.4.2 Strategic choices 202
17.1.1.4.3 Weaknesses and competitive threats 202
17.1.2 BALCHEM CORP. 203
17.1.2.1 Business overview 203
17.1.2.2 Products/Solutions/Services offered 204
17.1.2.3 Recent developments 205
17.1.2.3.1 Product launches/developments 205
17.1.2.3.2 Deals 205
17.1.2.3.3 Expansions 206
17.1.2.4 MnM view 206
17.1.2.4.1 Right to win 206
17.1.2.4.2 Strategic choices 207
17.1.2.4.3 Weaknesses and competitive threats 207
17.1.3 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.) 208
17.1.3.1 Business overview 208
17.1.3.2 Products/Solutions/Services offered 209
17.1.3.3 Recent developments 210
17.1.3.3.1 Product launches/developments 210
17.1.3.3.2 Deals 210
17.1.3.4 MnM view 211
17.1.3.4.1 Right to win 211
17.1.3.4.2 Strategic choices 211
17.1.3.4.3 Weaknesses and competitive threats 211
17.1.4 NOVONESIS GROUP 212
17.1.4.1 Business overview 212
17.1.4.2 Products/Solutions/Services offered 213
17.1.4.3 Recent developments 214
17.1.4.3.1 Deals 214
17.1.4.4 MnM view 214
17.1.4.4.1 Right to win 214
17.1.4.4.2 Strategic choices 214
17.1.4.4.3 Weaknesses and competitive threats 214
17.1.5 GUANGDONG SUNGEN BIOSCIENCE CO., LTD. 215
17.1.5.1 Business overview 215
17.1.5.2 Products/Solutions/Services offered 215
17.1.5.3 Recent developments 216
17.1.5.3.1 Other developments 216
17.1.5.4 MnM view 216
17.1.5.4.1 Right to win 216
17.1.5.4.2 Strategic choices 216
17.1.5.4.3 Weaknesses and competitive threats 216
17.1.6 VESTA NUTRA 217
17.1.6.1 Business overview 217
17.1.6.2 Products/Solutions/Services offered 217
17.1.6.3 Recent developments 218
17.1.6.4 MnM view 218
17.1.7 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD. 219
17.1.7.1 Business overview 219
17.1.7.2 Products/Solutions/Services offered 219
17.1.7.3 Recent developments 220
17.1.7.3.1 Product launches/developments 220
17.1.7.3.2 Other developments 220
17.1.7.4 MnM view 221
17.1.8 MENADIONA 222
17.1.8.1 Business overview 222
17.1.8.2 Products/Solutions/Services offered 222
17.1.8.3 Recent developments 223
17.1.8.3.1 Product launches/developments 223
17.1.8.4 MnM view 223
17.1.9 GF FERMENTECH CO., LTD. 224
17.1.9.1 Business overview 224
17.1.9.2 Products/Solutions/Services offered 225
17.1.9.3 Recent developments 225
17.1.9.3.1 Product launches/developments 225
17.1.9.3.2 Deals 226
17.1.9.4 MnM view 226
17.1.10 ANGELYEAST CO., LTD. 227
17.1.10.1 Business overview 227
17.1.10.2 Products/Solutions/Services offered 227
17.1.10.3 Recent developments 228
17.1.10.3.1 Expansions 228
17.1.10.4 MnM view 228
17.1.11 GENEFERM BIOTECHNOLOGY CO., LTD. 229
17.1.11.1 Business overview 229
17.1.11.2 Products/Solutions/Services offered 230
17.1.11.3 Recent developments 231
17.1.11.3.1 Expansions 231
17.1.11.4 MnM view 231
17.1.12 NAKODA CHEMICALS LTD. 232
17.1.12.1 Business overview 232
17.1.12.2 Products/Solutions/Services offered 232
17.1.12.3 Recent developments 233
17.1.12.4 MnM view 233
17.1.13 HAIHANG INDUSTRY CO., LTD. 234
17.1.13.1 Business overview 234
17.1.13.2 Products/Solutions/Services offered 234
17.1.13.3 Recent developments 234
17.1.13.4 MnM view 235
17.1.14 CHEMICEA LIMITED 236
17.1.14.1 Business overview 236
17.1.14.2 Products/Solutions/Services offered 236
17.1.14.3 Recent developments 236
17.1.14.4 MnM view 237
17.1.15 KYOWA HAKKO U.S.A., INC. 238
17.1.15.1 Business overview 238
17.1.15.2 Products/Solutions/Services offered 238
17.1.15.3 Recent developments 238
17.1.15.4 MnM view 238
17.2 DISTRIBUTORS/SUPPLIERS 239
17.2.1 SEEBIO BIOTECH (SHANGHAI) CO., LTD. 239
17.2.2 MAGNESIA GMBH 240
17.2.3 FALCON TRADING INTERNATIONAL 241
17.2.4 ABCO INDIA 242
17.2.5 ATLANTIC CHEMICALS TRADING GMBH 243

18 RESEARCH METHODOLOGY 244
18.1 RESEARCH DATA 244
18.1.1 SECONDARY DATA 245
18.1.1.1 Key data from secondary sources 245
18.1.2 PRIMARY DATA 245
18.1.2.1 Key data from primary sources 246
18.1.2.2 Breakdown of primary profiles 246
18.1.2.3 Key insights from industry experts 247
18.2 MARKET SIZE ESTIMATION 247
18.2.1 TOP-DOWN APPROACH 248
18.2.2 SUPPLY-SIDE ANALYSIS 249
18.2.3 BOTTOM-UP APPROACH (DEMAND SIDE) 249
18.3 DATA TRIANGULATION AND MARKET BREAKUP 251
18.4 RESEARCH ASSUMPTIONS 252
18.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 253

19 ADJACENT AND RELATED MARKETS 254
19.1 INTRODUCTION 254
19.2 RESEARCH LIMITATIONS 254
19.3 DIETARY SUPPLEMENTS MARKET 254
19.3.1 MARKET DEFINITION 254
19.3.2 MARKET OVERVIEW 255
19.4 VITAMINS MARKET 256
19.4.1 MARKET DEFINITION 256
19.4.2 MARKET OVERVIEW 256

20 APPENDIX 258
20.1 DISCUSSION GUIDE 258
20.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 263
20.3 CUSTOMIZATION OPTIONS 265
20.4 RELATED REPORTS 265
20.5 AUTHOR DETAILS 266

ページTOPに戻る

List of Tables/Graphs

FIGURE 1 MARKET SCENARIO 32.
FIGURE 2 VITAMIN K2 MARKET, 2022–2031 33.
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN VITAMIN K2, 2022–JUNE 2026 34.
FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF VITAMIN K2 MARKET 35.
FIGURE 5 VITAMIN K2 MARKET: HIGH-GROWTH SEGMENTS, 2026–2031 36.
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 37.
FIGURE 7 RISING DEMAND FOR PREVENTIVE HEALTHCARE AND NATURALLY FERMENTED VITAMIN K2 TO CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS 38.
FIGURE 8 CAPSULES & TABLETS SEGMENT AND NORTH AMERICA TO.
ACCOUNT FOR LARGEST MARKET SHARES IN 2026 39.
FIGURE 9 NATURAL SEGMENT TO DOMINATE MARKET IN 2026 39.
FIGURE 10 HEALTH SUPPLEMENTS SEGMENT TO ACCOUNT FOR.
LARGEST MARKET SHARE IN 2026 40.
FIGURE 11 MK7 SEGMENT TO DOMINATE MARKET IN 2026 40.
FIGURE 12 CAPSULES & TABLETS SEGMENT TO ACCOUNT FOR.
LARGEST MARKET SHARE IN 2026 41.
FIGURE 13 US TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026 41.
FIGURE 14 VITAMIN K2 MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 43.
FIGURE 15 HEALTH EXPENDITURE AS SHARE OF GDP FOR SELECTED COUNTRIES,.
2014–2024 44.
FIGURE 16 VITAMIN K2 MARKET: PORTER’S FIVE FORCES ANALYSIS 55.
FIGURE 17 GDP TRENDS AND FORECAST OF MAJOR ECONOMIES, 2023–2030 (USD BILLION) 58.
FIGURE 18 GLOBAL POPULATION GROWTH, 2000–2100 (BILLION) 58.
FIGURE 19 GLOBAL TRENDS IN DEATHS DUE TO CVD, 1990–2030 59.
FIGURE 20 VITAMIN K2 MARKET: VALUE CHAIN ANALYSIS 60.
FIGURE 21 VITAMIN K2 MARKET: ECOSYSTEM ANALYSIS 62.
FIGURE 22 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TONS) 65.
FIGURE 23 IMPORT OF HS CODE 293629, BY KEY COUNTRY, 2021–2025 (USD MILLION) 66.
FIGURE 24 EXPORT OF HS CODE 293629, BY KEY COUNTRY, 2021–2025, (USD MILLION) 67.
FIGURE 25 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS 69.
FIGURE 26 INVESTMENT AND FUNDING SCENARIO 69.
FIGURE 27 NUMBER OF PATENTS APPLIED AND GRANTED, 2016–2026 77.
FIGURE 28 FUTURE APPLICATIONS 78.
FIGURE 29 VITAMIN K2 MARKET DECISION-MAKING FACTORS 94.
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR.
VITAMIN K2 PRODUCT TYPES 96.
FIGURE 31 KEY BUYING CRITERIA FOR VITAMIN K2 PRODUCT TYPES 97.
FIGURE 32 ADOPTION BARRIERS AND INTERNAL CHALLENGES 98.
FIGURE 33 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026 VS. 2031 113.
FIGURE 34 VITAMIN K2 MARKET, BY SOURCE, 2026 VS. 2031 120.
FIGURE 35 VITAMIN K2 MARKET, BY APPLICATION, 2026 VS. 2031 125.
FIGURE 36 VITAMIN K2 MARKET, BY APPLICATION FORM, 2026 VS. 2031 135.
FIGURE 37 ITALY TO RECORD HIGHEST GROWTH RATE DURING FORECAST PERIOD 140.
FIGURE 38 NORTH AMERICA: VITAMIN K2 MARKET SNAPSHOT 142.
FIGURE 39 ASIA PACIFIC: VITAMIN K2 MARKET SNAPSHOT 159.
FIGURE 40 REVENUE ANALYSIS OF KEY COMPANIES, 2023–2025 (USD BILLION) 178.
FIGURE 41 SHARE OF LEADING COMPANIES IN VITAMIN K2 MARKET, 2025 179.
FIGURE 42 COMPARATIVE ANALYSIS OF VENDOR BRANDS 182.
FIGURE 43 VITAMIN K2 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 185.
FIGURE 44 VITAMIN K2 MARKET: COMPANY FOOTPRINT 186.
FIGURE 45 VITAMIN K2 MARKET: COMPANY EVALUATION MATRIX (DISTRIBUTORS/SUPPLIERS), 2025 190.
FIGURE 46 COMPANY VALUATION OF KEY VITAMIN K2 VENDORS 192.
FIGURE 47 EV/EBITDA OF KEY COMPANIES 192.
FIGURE 48 BALCHEM CORP.: COMPANY SNAPSHOT 204.
FIGURE 49 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.): COMPANY SNAPSHOT 209.
FIGURE 50 NOVONESIS GROUP: COMPANY SNAPSHOT 213.
FIGURE 51 GENEFERM BIOTECHNOLOGY CO., LTD.: COMPANY SNAPSHOT 230.
FIGURE 52 VITAMIN K2 MARKET: RESEARCH DESIGN 244.
FIGURE 53 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,.
DESIGNATION, AND REGION 246.
FIGURE 54 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 248.
FIGURE 55 SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP 249.
FIGURE 56 VITAMIN K2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 250.
FIGURE 57 DATA TRIANGULATION 251.
TABLE 1 INCLUSIONS AND EXCLUSIONS 28.
TABLE 2 USD EXCHANGE RATES, 2022–2025 30.
TABLE 3 IMPACT OF PORTER’S FIVE FORCES ON VITAMIN K2 MARKET 55.
TABLE 4 VITAMIN K2 MARKET: SUPPLY SIDE (ECOSYSTEM) 63.
TABLE 5 AVERAGE SELLING PRICE (ASP) TREND, BY PRODUCT TYPE,.
2022–2025 (USD/TONS) 64.
TABLE 6 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022–2025 (USD/TONS) 65.
TABLE 7 TOP IMPORTERS OF VITAMINS AND THEIR DERIVATIVES,.
2021–2025 (USD MILLION) 66.
TABLE 8 TOP EXPORTERS OF VITAMINS AND THEIR DERIVATIVES,.
2021–2025 (USD MILLION) 67.
TABLE 9 VITAMIN K2 MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026–2027 68.
TABLE 10 PATENTS PERTAINING TO VITAMIN K2 MARKET, 2024–2026 77.
TABLE 11 VITAMIN K2 MARKET: CASE STUDIES RELATED TO GENERATIVE AI IMPLEMENTATION 82.
TABLE 12 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 82.
TABLE 13 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,.
AND OTHER ORGANIZATIONS 84.
TABLE 14 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,.
AND OTHER ORGANIZATIONS 85.
TABLE 15 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,.
AND OTHER ORGANIZATIONS 85.
TABLE 16 INTERNATIONAL: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,.
AND OTHER ORGANIZATIONS 86.
TABLE 17 GLOBAL INDUSTRY STANDARDS IN VITAMIN K2 MARKET 87.
TABLE 18 LABELING REQUIREMENTS AND CLAIMS IN VITAMIN K2 MARKET 88.
TABLE 19 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN VITAMIN K2 MARKET 92.
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR.
VITAMIN K2 PRODUCT TYPES 96.
TABLE 21 KEY BUYING CRITERIA FOR VITAMIN K2 PRODUCT TYPES 97.
TABLE 22 UNMET NEEDS IN VITAMIN K2 MARKET,.
BY APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN 99.
TABLE 23 COST DYNAMICS IN VITAMIN K2 MARKET 102.
TABLE 24 MARGIN OPPORTUNITIES IN VITAMIN K2 MARKET, BY PRODUCT TYPE 103.
TABLE 25 PRODUCTION TECHNOLOGY APPLIED BY KEY PLAYERS 108.
TABLE 26 PRODUCT TYPE: OVERVIEW 112.
TABLE 27 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION) 113.
TABLE 28 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION) 113.
TABLE 29 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (TON) 113.
TABLE 30 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (TON) 114.
TABLE 31 MK7: VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 114.
TABLE 32 MK7: VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 115.
TABLE 33 MK7: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION) 115.
TABLE 34 MK7: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION) 115.
TABLE 35 MK7: VITAMIN K2 MARKET, BY REGION, 2022–2025 (TON) 115.
TABLE 36 MK7: VITAMIN K2 MARKET, BY REGION, 2026–2031 (TON) 116.
TABLE 37 MK4: VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 116.
TABLE 38 MK4: VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 117.
TABLE 39 MK4: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION) 117.
TABLE 40 MK4: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION) 117.
TABLE 41 MK4: VITAMIN K2 MARKET, BY REGION, 2022–2025 (TON) 117.
TABLE 42 MK4: VITAMIN K2 MARKET, BY REGION, 2026–2031 (TON) 118.
TABLE 43 VITAMIN K2 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 121.
TABLE 44 VITAMIN K2 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 121.
TABLE 45 NATURAL: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION) 122.
TABLE 46 NATURAL: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION) 122.
TABLE 47 SYNTHETIC: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION) 123.
TABLE 48 SYNTHETIC: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION) 123.
TABLE 49 VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 125.
TABLE 50 VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 126.
TABLE 51 HEALTH SUPPLEMENTS: VITAMIN K2 MARKET, BY REGION,.
2022–2025 (USD MILLION) 127.
TABLE 52 HEALTH SUPPLEMENTS: VITAMIN K2 MARKET, BY REGION,.
2026–2031 (USD MILLION) 127.
TABLE 53 HEALTH SUPPLEMENTS: MK7 VITAMIN K2 MARKET, BY REGION,.
2022–2025 (USD MILLION) 127.
TABLE 54 HEALTH SUPPLEMENTS: MK7 VITAMIN K2 MARKET, BY REGION,.
2026–2031 (USD MILLION) 128.
TABLE 55 HEALTH SUPPLEMENTS: MK4 VITAMIN K2 MARKET, BY REGION,.
2022–2025 (USD MILLION) 128.
TABLE 56 HEALTH SUPPLEMENTS: MK4 VITAMIN K2 MARKET, BY REGION,.
2026–2031 (USD MILLION) 128.
TABLE 57 FUNCTIONAL FOOD & BEVERAGES: VITAMIN K2 MARKET, BY REGION,.
2022–2025 (USD MILLION) 129.
TABLE 58 FUNCTIONAL FOOD & BEVERAGES: VITAMIN K2 MARKET, BY REGION,.
2026–2031 (USD MILLION) 129.
TABLE 59 FUNCTIONAL FOOD & BEVERAGES: MK7 VITAMIN K2 MARKET, BY REGION,.
2022–2025 (USD MILLION) 130.
TABLE 60 FUNCTIONAL FOOD & BEVERAGES: MK7 VITAMIN K2 MARKET, BY REGION,.
2026–2031 (USD MILLION) 130.
TABLE 61 FUNCTIONAL FOOD & BEVERAGES: MK4 VITAMIN K2 MARKET, BY REGION,.
2022–2025 (USD MILLION) 130.
TABLE 62 FUNCTIONAL FOOD & BEVERAGES: MK4 VITAMIN K2 MARKET, BY REGION,.
2026–2031 (USD MILLION) 131.
TABLE 63 PHARMACEUTICALS: VITAMIN K2 MARKET, BY REGION,.
2022–2025 (USD MILLION) 131.
TABLE 64 PHARMACEUTICALS: VITAMIN K2 MARKET, BY REGION,.
2026–2031 (USD MILLION) 132.
TABLE 65 PHARMACEUTICALS: MK7 VITAMIN K2 MARKET, BY REGION,.
2022–2025 (USD MILLION) 132.
TABLE 66 PHARMACEUTICALS: MK7 VITAMIN K2 MARKET, BY REGION,.
2026–2031 (USD MILLION) 132.
TABLE 67 PHARMACEUTICALS: MK4 VITAMIN K2 MARKET, BY REGION,.
2022–2025 (USD MILLION) 132.
TABLE 68 PHARMACEUTICALS: MK4 VITAMIN K2 MARKET, BY REGION,.
2026–2031 (USD MILLION) 133.
TABLE 69 VITAMIN K2 MARKET, BY APPLICATION FORM, 2022–2025 (USD MILLION) 135.
TABLE 70 VITAMIN K2 MARKET, BY APPLICATION FORM, 2026–2031 (USD MILLION) 136.
TABLE 71 CAPSULES & TABLETS: VITAMIN K2 MARKET, BY REGION,.
2022–2025 (USD MILLION) 136.
TABLE 72 CAPSULES & TABLETS: VITAMIN K2 MARKET, BY REGION,.
2026–2031 (USD MILLION) 137.
TABLE 73 POWDER & CRYSTALLINE: VITAMIN K2 MARKET, BY REGION,.
2022–2025 (USD MILLION) 137.
TABLE 74 POWDER & CRYSTALLINE: VITAMIN K2 MARKET, BY REGION,.
2026–2031 (USD MILLION) 137.
TABLE 75 LIQUIDS: VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION) 138.
TABLE 76 LIQUIDS: VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION) 138.
TABLE 77 VITAMIN K2 MARKET, BY REGION, 2022–2025 (USD MILLION) 141.
TABLE 78 VITAMIN K2 MARKET, BY REGION, 2026–2031 (USD MILLION) 141.
TABLE 79 VITAMIN K2 MARKET, BY REGION, 2022–2025 (TON) 141.
TABLE 80 VITAMIN K2 MARKET, BY REGION, 2026–2031 (TON) 141.
TABLE 81 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 142.
TABLE 82 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 143.
TABLE 83 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2022–2025 (TON) 143.
TABLE 84 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2026–2031 (TON) 143.
TABLE 85 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE,.
2022–2025 (USD MILLION) 143.
TABLE 86 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE,.
2026–2031 (USD MILLION) 143.
TABLE 87 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (TON) 144.
TABLE 88 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (TON) 144.
TABLE 89 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION FORM,.
2022–2025 (USD MILLION) 144.
TABLE 90 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION FORM,.
2026–2031 (USD MILLION) 144.
TABLE 91 NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 145.
TABLE 92 NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 145.
TABLE 93 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION,.
2022–2025 (USD MILLION) 145.
TABLE 94 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 145.
TABLE 95 NORTH AMERICA: MK7 VITAMIN K2 MARKET, BY APPLICATION,.
2022–2025 (USD MILLION) 146.
TABLE 96 NORTH AMERICA: MK7 VITAMIN K2 MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 146.
TABLE 97 NORTH AMERICA: MK4 VITAMIN K2 MARKET, BY APPLICATION,.
2022–2025 (USD MILLION) 146.
TABLE 98 NORTH AMERICA: MK4 VITAMIN K2 MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 146.
TABLE 99 US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION) 147.
TABLE 100 US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION) 147.
TABLE 101 CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION) 148.
TABLE 102 CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION) 148.
TABLE 103 MEXICO: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION) 148.
TABLE 104 MEXICO: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION) 149.
TABLE 105 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 149.
TABLE 106 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 150.
TABLE 107 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2022–2025 (TON) 150.
TABLE 108 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2026–2031 (TON) 150.
TABLE 109 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION) 151.
TABLE 110 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION) 151.
TABLE 111 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (TON) 151.
TABLE 112 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (TON) 151.
TABLE 113 EUROPE: VITAMIN K2 MARKET, BY APPLICATION FORM,.
2022–2025 (USD MILLION) 151.
TABLE 114 EUROPE: VITAMIN K2 MARKET, BY APPLICATION FORM,.
2026–2031 (USD MILLION) 152.
TABLE 115 EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 152.
TABLE 116 EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 152.
TABLE 117 EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 152.
TABLE 118 EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 153.
TABLE 119 EUROPE: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 153.
TABLE 120 EUROPE: MK7 VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 153.
TABLE 121 EUROPE: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 153.
TABLE 122 EUROPE: MK4 VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 154.
TABLE 123 GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION) 154.
TABLE 124 GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION) 154.
TABLE 125 FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION) 155.
TABLE 126 FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION) 155.
TABLE 127 UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION) 156.
TABLE 128 UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION) 156.
TABLE 129 ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION) 157.
TABLE 130 ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION) 157.
TABLE 131 SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION) 157.
TABLE 132 SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION) 158.
TABLE 133 REST OF EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE,.
2022–2025 (USD MILLION) 158.
TABLE 134 REST OF EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE,.
2026–2031 (USD MILLION) 158.
TABLE 135 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2022–2025 (USD MILLION) 160.
TABLE 136 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2026–2031 (USD MILLION) 160.
TABLE 137 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2022–2025 (TON) 160.
TABLE 138 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2026–2031 (TON) 161.
TABLE 139 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE,.
2022–2025 (USD MILLION) 161.
TABLE 140 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE,.
2026–2031 (USD MILLION) 161.
TABLE 141 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (TON) 161.
TABLE 142 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (TON) 162.
TABLE 143 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION FORM,.
2022–2025 (USD MILLION) 162.
TABLE 144 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION FORM,.
2026–2031 (USD MILLION) 162.
TABLE 145 ASIA PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2022–2025 (USD MILLION) 162.
TABLE 146 ASIA PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2026–2031 (USD MILLION) 163.
TABLE 147 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2022–2025 (USD MILLION) 163.
TABLE 148 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2026–2031 (USD MILLION) 163.
TABLE 149 ASIA PACIFIC: MK7 VITAMIN K2 MARKET, BY APPLICATION,.
2022–2025 (USD MILLION) 163.
TABLE 150 ASIA PACIFIC: MK7 VITAMIN K2 MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 164.
TABLE 151 ASIA PACIFIC: MK4 VITAMIN K2 MARKET, BY APPLICATION,.
2022–2025 (USD MILLION) 164.
TABLE 152 ASIA PACIFIC: MK4 VITAMIN K2 MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 164.
TABLE 153 CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION) 165.
TABLE 154 CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION) 165.
TABLE 155 JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION) 166.
TABLE 156 JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION) 166.
TABLE 157 INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2022–2025 (USD MILLION) 167.
TABLE 158 INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2026–2031 (USD MILLION) 167.
TABLE 159 AUSTRALIA AND NEW ZEALAND: VITAMIN K2 MARKET, BY PRODUCT TYPE,.
2022–2025 (USD MILLION) 168.
TABLE 160 AUSTRALIA AND NEW ZEALAND: VITAMIN K2 MARKET, BY PRODUCT TYPE,.
2026–2031 (USD MILLION) 168.
TABLE 161 REST OF ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE,.
2022–2025 (USD MILLION) 168.
TABLE 162 REST OF ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE,.
2026–2031 (USD MILLION) 169.
TABLE 163 REST OF THE WORLD: VITAMIN K2 MARKET, BY REGION,.
2022–2025 (USD MILLION) 169.
TABLE 164 REST OF THE WORLD: VITAMIN K2 MARKET, BY REGION,.
2026–2031 (USD MILLION) 169.
TABLE 165 REST OF THE WORLD: VITAMIN K2 MARKET, BY REGION, 2022–2025 (TON) 170.
TABLE 166 REST OF THE WORLD: VITAMIN K2 MARKET, BY REGION, 2026–2031 (TON) 170.
TABLE 167 REST OF THE WORLD: VITAMIN K2 MARKET, BY PRODUCT TYPE,.
2022–2025 (USD MILLION) 170.
TABLE 168 REST OF THE WORLD: VITAMIN K2 MARKET, BY PRODUCT TYPE,.
2026–2031 (USD MILLION) 170.
TABLE 169 REST OF THE WORLD: VITAMIN K2 MARKET, BY PRODUCT TYPE,.
2022–2025 (TON) 170.
TABLE 170 REST OF THE WORLD: VITAMIN K2 MARKET, BY PRODUCT TYPE,.
2026–2031 (TON) 171.
TABLE 171 REST OF THE WORLD: VITAMIN K2 MARKET, BY APPLICATION FORM,.
2022–2025 (USD MILLION) 171.
TABLE 172 REST OF THE WORLD: VITAMIN K2 MARKET, BY APPLICATION FORM,.
2026–2031 (USD MILLION) 171.
TABLE 173 REST OF THE WORLD: VITAMIN K2 MARKET, BY SOURCE,.
2022–2025 (USD MILLION) 171.
TABLE 174 REST OF THE WORLD: VITAMIN K2 MARKET, BY SOURCE,.
2026–2031 (USD MILLION) 172.
TABLE 175 REST OF THE WORLD: VITAMIN K2 MARKET, BY APPLICATION,.
2022–2025 (USD MILLION) 172.
TABLE 176 REST OF THE WORLD: VITAMIN K2 MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 172.
TABLE 177 REST OF THE WORLD: MK7 VITAMIN K2 MARKET, BY APPLICATION,.
2022–2025 (USD MILLION) 172.
TABLE 178 REST OF THE WORLD: MK7 VITAMIN K2 MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 173.
TABLE 179 REST OF THE WORLD: MK4 VITAMIN K2 MARKET, BY APPLICATION,.
2022–2025 (USD MILLION) 173.
TABLE 180 REST OF THE WORLD: MK4 VITAMIN K2 MARKET, BY APPLICATION,.
2026–2031 (USD MILLION) 173.
TABLE 181 SOUTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE,.
2022–2025 (USD MILLION) 174.
TABLE 182 SOUTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE,.
2026–2031 (USD MILLION) 174.
TABLE 183 MIDDLE EAST & AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE,.
2022–2025 (USD MILLION) 175.
TABLE 184 MIDDLE EAST & AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE,.
2026–2031 (USD MILLION) 175.
TABLE 185 OVERVIEW OF STRATEGIES ADOPTED BY KEY VITAMIN K2 VENDORS, 2021–2026 176.
TABLE 186 VITAMIN K2 MARKET: DEGREE OF COMPETITION 179.
TABLE 187 VITAMIN K2 MARKET: REGION FOOTPRINT 187.
TABLE 188 VITAMIN K2 MARKET: APPLICATION FOOTPRINT 188.
TABLE 189 VITAMIN K2 MARKET: PRODUCT TYPE FOOTPRINT 189.
TABLE 190 VITAMIN K2 MARKET: KEY DISTRIBUTORS/SUPPLIERS, 2025 191.
TABLE 191 VITAMIN K2 MARKET: COMPETITIVE BENCHMARKING OF.
KEY DISTRIBUTORS/SUPPLIERS 191.
TABLE 192 VITAMIN K2 MARKET: PRODUCT LAUNCHES/DEVELOPMENTS, 2021–JUNE 2026 193.
TABLE 193 VITAMIN K2 MARKET: DEALS, 2021–JUNE 2026 195.
TABLE 194 VITAMIN K2 MARKET: EXPANSIONS, 2021–JUNE 2026 197.
TABLE 195 VITAMIN K2 MARKET: OTHER DEVELOPMENTS, 2021–JUNE 2026 198.
TABLE 196 GNOSIS BY LESAFFRE: COMPANY OVERVIEW 199.
TABLE 197 GNOSIS BY LESAFFRE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 200.
TABLE 198 GNOSIS BY LESAFFRE: PRODUCT LAUNCHES/DEVELOPMENTS 201.
TABLE 199 GNOSIS BY LESAFFRE: DEALS 201.
TABLE 200 BALCHEM CORP.: COMPANY OVERVIEW 203.
TABLE 201 BALCHEM CORP.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 204.
TABLE 202 BALCHEM CORP.: PRODUCT LAUNCHES/DEVELOPMENTS 205.
TABLE 203 BALCHEM CORP.: DEALS 205.
TABLE 204 BALCHEM CORP.: EXPANSIONS 206.
TABLE 205 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.): COMPANY OVERVIEW 208.
TABLE 206 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.):.
PRODUCTS/SOLUTIONS/ SERVICES OFFERED 209.
TABLE 207 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.):.
PRODUCT LAUNCHES/DEVELOPMENTS 210.
TABLE 208 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.): DEALS 210.
TABLE 209 NOVONESIS GROUP: COMPANY OVERVIEW 212.
TABLE 210 NOVONESIS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 213.
TABLE 211 NOVONESIS GROUP: DEALS 214.
TABLE 212 GUANGDONG SUNGEN BIOSCIENCE CO., LTD.: COMPANY OVERVIEW 215.
TABLE 213 GUANGDONG SUNGEN BIOSCIENCE CO., LTD.:.
PRODUCTS/SOLUTIONS/ SERVICES OFFERED 215.
TABLE 214 GUANGDONG SUNGEN BIOSCIENCE CO., LTD.: OTHER DEVELOPMENTS 216.
TABLE 215 VESTA NUTRA: COMPANY OVERVIEW 217.
TABLE 216 VESTA NUTRA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 217.
TABLE 217 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 219.
TABLE 218 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.:.
PRODUCTS/SOLUTIONS/SERVICES OFFERED 219.
TABLE 219 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.:.
PRODUCT LAUNCHES/DEVELOPMENTS 220.
TABLE 220 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: OTHER DEVELOPMENTS 220.
TABLE 221 MENADIONA: COMPANY OVERVIEW 222.
TABLE 222 MENADIONA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 222.
TABLE 223 MENADIONA: PRODUCT LAUNCHES/DEVELOPMENTS 223.
TABLE 224 GF FERMENTECH CO., LTD.: COMPANY OVERVIEW 224.
TABLE 225 GF FERMENTECH CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 225.
TABLE 226 GF FERMENTECH CO., LTD.: PRODUCT LAUNCHES/DEVELOPMENTS 225.
TABLE 227 GF FERMENTECH CO., LTD.: DEALS 226.
TABLE 228 ANGELYEAST CO., LTD.: COMPANY OVERVIEW 227.
TABLE 229 ANGELYEAST CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 227.
TABLE 230 ANGELYEAST CO., LTD.: EXPANSIONS 228.
TABLE 231 GENEFERM BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW 229.
TABLE 232 GENEFERM BIOTECHNOLOGY CO., LTD.:.
PRODUCTS/SOLUTIONS/SERVICES OFFERED 230.
TABLE 233 GENEFERM BIOTECHNOLOGY CO., LTD.: EXPANSIONS 231.
TABLE 234 NAKODA CHEMICALS LTD.: COMPANY OVERVIEW 232.
TABLE 235 NAKODA CHEMICALS LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 232.
TABLE 236 HAIHANG INDUSTRY CO., LTD.: COMPANY OVERVIEW 234.
TABLE 237 HAIHANG INDUSTRY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 234.
TABLE 238 CHEMICEA LIMITED: COMPANY OVERVIEW 236.
TABLE 239 CHEMICEA LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 236.
TABLE 240 KYOWA HAKKO U.S.A., INC.: BUSINESS OVERVIEW 238.
TABLE 241 KYOWA HAKKO U.S.A., INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 238.
TABLE 242 SEEBIO BIOTECH (SHANGHAI) CO., LTD.: COMPANY OVERVIEW 239.
TABLE 243 MAGNESIA GMBH: COMPANY OVERVIEW 240.
TABLE 244 FALCON TRADING INTERNATIONAL: COMPANY OVERVIEW 241.
TABLE 245 ABCO INDIA: COMPANY OVERVIEW 242.
TABLE 246 ATLANTIC CHEMICALS TRADING GMBH: COMPANY OVERVIEW 243.
TABLE 247 MARKETS ADJACENT TO VITAMIN K2 MARKET 254.
TABLE 248 DIETARY SUPPLEMENTS MARKET, BY MODE OF APPLICATION,.
2020–2023 (USD MILLION) 255.
TABLE 249 DIETARY SUPPLEMENTS MARKET, BY MODE OF APPLICATION,.
2024–2029 (USD MILLION) 256.
TABLE 250 VITAMINS MARKET, BY SOURCE, 2017–2022 (USD MILLION) 257.
TABLE 251 VITAMINS MARKET, BY SOURCE, 2023–2028 (USD MILLION) 257.